A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease

Name: A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
Creator: Vivli
Published: 2026-03-24 13:50:57
License: 暂无描述

DataCite Commons2026-03-24 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012872/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The main purpose of this study is to compare donanemab to aducanumab on brain amyloid plaque clearance in participants with early symptomatic Alzheimer's Disease (AD).

提供机构：

Vivli

创建时间：

2026-03-24